619 related articles for article (PubMed ID: 35163176)
1. The Role of Sphingolipid Signaling in Oxidative Lung Injury and Pathogenesis of Bronchopulmonary Dysplasia.
Thomas JM; Sudhadevi T; Basa P; Ha AW; Natarajan V; Harijith A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163176
[TBL] [Abstract][Full Text] [Related]
2. Neonatal therapy with PF543, a sphingosine kinase 1 inhibitor, ameliorates hyperoxia-induced airway remodeling in a murine model of bronchopulmonary dysplasia.
Ha AW; Sudhadevi T; Ebenezer DL; Fu P; Berdyshev EV; Ackerman SJ; Natarajan V; Harijith A
Am J Physiol Lung Cell Mol Physiol; 2020 Sep; 319(3):L497-L512. PubMed ID: 32697651
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine kinase 1 deficiency confers protection against hyperoxia-induced bronchopulmonary dysplasia in a murine model: role of S1P signaling and Nox proteins.
Harijith A; Pendyala S; Reddy NM; Bai T; Usatyuk PV; Berdyshev E; Gorshkova I; Huang LS; Mohan V; Garzon S; Kanteti P; Reddy SP; Raj JU; Natarajan V
Am J Pathol; 2013 Oct; 183(4):1169-1182. PubMed ID: 23933064
[TBL] [Abstract][Full Text] [Related]
4. Amelioration of hyperoxia-induced lung injury using a sphingolipid-based intervention.
Tibboel J; Joza S; Reiss I; de Jongste JC; Post M
Eur Respir J; 2013 Sep; 42(3):776-84. PubMed ID: 23143542
[TBL] [Abstract][Full Text] [Related]
5. Expression profiling of genes regulated by sphingosine kinase1 signaling in a murine model of hyperoxia induced neonatal bronchopulmonary dysplasia.
Natarajan V; Ha AW; Dong Y; Reddy NM; Ebenezer DL; Kanteti P; Reddy SP; Usha Raj J; Lei Z; Maienschein-Cline M; Arbieva Z; Harijith A
BMC Genomics; 2017 Aug; 18(1):664. PubMed ID: 28851267
[TBL] [Abstract][Full Text] [Related]
6. Exogenous hydrogen sulfide (H2S) protects alveolar growth in experimental O2-induced neonatal lung injury.
Vadivel A; Alphonse RS; Ionescu L; Machado DS; O'Reilly M; Eaton F; Haromy A; Michelakis ED; Thébaud B
PLoS One; 2014; 9(3):e90965. PubMed ID: 24603989
[TBL] [Abstract][Full Text] [Related]
7. Tracheal aspirate VEGF and sphingolipid metabolites in the preterm infant with later development of bronchopulmonary dysplasia.
Hendricks-Muñoz KD; Xu J; Voynow JA
Pediatr Pulmonol; 2018 Aug; 53(8):1046-1052. PubMed ID: 29687638
[TBL] [Abstract][Full Text] [Related]
8. Airway Remodeling and Hyperreactivity in a Model of Bronchopulmonary Dysplasia and Their Modulation by IL-1 Receptor Antagonist.
Royce SG; Nold MF; Bui C; Donovan C; Lam M; Lamanna E; Rudloff I; Bourke JE; Nold-Petry CA
Am J Respir Cell Mol Biol; 2016 Dec; 55(6):858-868. PubMed ID: 27482635
[TBL] [Abstract][Full Text] [Related]
9. Reduced platelet-derived growth factor receptor expression is a primary feature of human bronchopulmonary dysplasia.
Popova AP; Bentley JK; Cui TX; Richardson MN; Linn MJ; Lei J; Chen Q; Goldsmith AM; Pryhuber GS; Hershenson MB
Am J Physiol Lung Cell Mol Physiol; 2014 Aug; 307(3):L231-9. PubMed ID: 24907056
[TBL] [Abstract][Full Text] [Related]
10. Microbial-induced Redox Imbalance in the Neonatal Lung Is Ameliorated by Live Biotherapeutics.
Freeman AE; Willis KA; Qiao L; Abdelgawad AS; Halloran B; Rezonzew G; Nizami Z; Wenger N; Gaggar A; Ambalavanan N; Tipple TE; Lal CV
Am J Respir Cell Mol Biol; 2023 Mar; 68(3):267-278. PubMed ID: 36287630
[TBL] [Abstract][Full Text] [Related]
11. Alterations in VASP phosphorylation and profilin1 and cofilin1 expression in hyperoxic lung injury and BPD.
Ali M; Heyob K; Tipple TE; Pryhuber GS; Rogers LK
Respir Res; 2018 Nov; 19(1):229. PubMed ID: 30463566
[TBL] [Abstract][Full Text] [Related]
12. Hypoxic stress exacerbates hyperoxia-induced lung injury in a neonatal mouse model of bronchopulmonary dysplasia.
Ratner V; Slinko S; Utkina-Sosunova I; Starkov A; Polin RA; Ten VS
Neonatology; 2009; 95(4):299-305. PubMed ID: 19052476
[TBL] [Abstract][Full Text] [Related]
13. Hyperoxia-induced bronchopulmonary dysplasia: better models for better therapies.
Giusto K; Wanczyk H; Jensen T; Finck C
Dis Model Mech; 2021 Feb; 14(2):. PubMed ID: 33729989
[TBL] [Abstract][Full Text] [Related]
14. Treatment with Geranylgeranylacetone Induces Heat Shock Protein 70 and Attenuates Neonatal Hyperoxic Lung Injury in a Model of Bronchopulmonary Dysplasia.
Tokuriki S; Igarashi A; Okuno T; Ohta G; Naiki H; Ohshima Y
Lung; 2017 Aug; 195(4):469-476. PubMed ID: 28447205
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of β-catenin signaling improves alveolarization and reduces pulmonary hypertension in experimental bronchopulmonary dysplasia.
Alapati D; Rong M; Chen S; Hehre D; Hummler SC; Wu S
Am J Respir Cell Mol Biol; 2014 Jul; 51(1):104-13. PubMed ID: 24484510
[TBL] [Abstract][Full Text] [Related]
16. Activation of Akt protects alveoli from neonatal oxygen-induced lung injury.
Alphonse RS; Vadivel A; Coltan L; Eaton F; Barr AJ; Dyck JR; Thébaud B
Am J Respir Cell Mol Biol; 2011 Feb; 44(2):146-54. PubMed ID: 20348209
[TBL] [Abstract][Full Text] [Related]
17. Blocking SphK1/S1P/S1PR1 Signaling Pathway Alleviates Lung Injury Caused by Sepsis in Acute Ethanol Intoxication Mice.
Chen L; Li L; Song Y; Lv T
Inflammation; 2021 Dec; 44(6):2170-2179. PubMed ID: 34109517
[TBL] [Abstract][Full Text] [Related]
18. Loss of microRNA-30a and sex-specific effects on the neonatal hyperoxic lung injury.
Grimm SL; Reddick S; Dong X; Leek C; Wang AX; Gutierrez MC; Hartig SM; Moorthy B; Coarfa C; Lingappan K
Biol Sex Differ; 2023 Aug; 14(1):50. PubMed ID: 37553579
[TBL] [Abstract][Full Text] [Related]
19. Acute and chronic changes in the control of breathing in a rat model of bronchopulmonary dysplasia.
Mouradian GC; Alvarez-Argote S; Gorzek R; Thuku G; Michkalkiewicz T; Wong-Riley MTT; Konduri GG; Hodges MR
Am J Physiol Lung Cell Mol Physiol; 2019 Mar; 316(3):L506-L518. PubMed ID: 30652496
[TBL] [Abstract][Full Text] [Related]
20. Foxm1 regulates resolution of hyperoxic lung injury in newborns.
Xia H; Ren X; Bolte CS; Ustiyan V; Zhang Y; Shah TA; Kalin TV; Whitsett JA; Kalinichenko VV
Am J Respir Cell Mol Biol; 2015 May; 52(5):611-21. PubMed ID: 25275225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
